APA (7th ed.) Citation

F, V., J, H., K, M., D, W., A, D., T, R., . . . DM, S. (2022). Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis. Blood advances, 6(16), 4847. https://doi.org/10.1182/bloodadvances.2022007364

Chicago Style (17th ed.) Citation

F, Vogiatzi, et al. "Venetoclax Enhances the Efficacy of Therapeutic Antibodies in B-cell Malignancies by Augmenting Tumor Cell Phagocytosis." Blood Advances 6, no. 16 (2022): 4847. https://doi.org/10.1182/bloodadvances.2022007364.

MLA (9th ed.) Citation

F, Vogiatzi, et al. "Venetoclax Enhances the Efficacy of Therapeutic Antibodies in B-cell Malignancies by Augmenting Tumor Cell Phagocytosis." Blood Advances, vol. 6, no. 16, 2022, p. 4847, https://doi.org/10.1182/bloodadvances.2022007364.